GLP-1 Support Blend

The biggest new formulation brief coming across our desk right now.

As millions of consumers cycle on and off GLP-1 medications like semaglutide and tirzepatide, a category is forming around muscle preservation, satiety support, gut health, and metabolic bridging. It's the brief we see more of than any other in 2026.

GLP-1 is reshaping the supplement industry faster than anything else we've seen this decade. Millions of consumers are cycling through semaglutide and tirzepatide prescriptions, and a lot of them are coming off. That's creating four very specific supplement needs: muscle preservation during rapid weight loss, satiety support after people come off the medication, gut health to deal with GI side effects, and metabolic bridging through the off-ramp.

GLP-1 support blends tend to pull from the same ingredient toolkit: protein sources (creatine, leucine, collagen), soluble fibers (glucomannan, PHGG), electrolytes, B-vitamins, and in some cases targeted botanicals like berberine, bitter melon, or inositol. The hardest part of this category isn't formulation. It's claim language. Any wording that implies the product treats, replaces, or substitutes for a prescription drug is a warning letter waiting to happen. We help founders build claim structures that stay on the right side of the line in both Canada and the USA.

Why Brands Choose GLP-1 Support Blend

Nobody owns it yet

No dominant brand has captured the GLP-1 support category so far. The founders moving first have a real chance to plant a flag before it gets crowded.

Multiple product angles from one positioning

On-GLP-1, off-GLP-1, and maintenance consumers each need different things. One brand position can support three or four distinct SKUs.

Consumers who already pay premium prices

This cohort has proven they'll pay for weight-management results. They're not price-sensitive shoppers.

Formulation Notes

Working with GLP-1 Support Blend

  • Typical stacks include protein + fiber + electrolytes + targeted actives.
  • Avoid any claim language that implies drug replacement or treatment of GLP-1 side effects. This is the #1 compliance risk.
  • Stick packs and powders are the favored formats because of dose volume and mixability.
  • Consider berberine, bitter melon, or inositol as targeted metabolic actives (with regulatory review).

Delivery Forms

PowderStick packCapsuleReady-to-drink

Considerations

  • Compliance is the single biggest risk in this category. Claim language must be carefully engineered.
  • Ingredient interactions with GLP-1 medications are an emerging research area; conservative positioning is recommended.

Regulatory Status

Canada (NPN)

All constituent ingredients must have NPN monograph coverage or full submissions. Claim structure must stay within NHP regulations.

USA (DSHEA)

DSHEA structure-function claims only. Avoid any disease claim or implied treatment of GLP-1 side effects.

Common Structure-Function Claims

  • Supports healthy protein intake during weight management
  • Supports digestive comfort
  • Helps support satiety as part of a balanced lifestyle

Claim language must be reviewed for your specific product and market before use. Not all claims are permitted in every jurisdiction.

Clinical Evidence & Market Demand

Selected peer-reviewed studies, plus the demand signals we're seeing from founders, retailers, and consumer search behaviour.

Primary literature

Market & consumer demand

GLP-1 companion supplements are the largest greenfield supplement category in 2025, with no dominant brand yet established.

By mid-2025, roughly 12% of US adults reported having taken or considered a GLP-1 medication. That cohort is generating four distinct supplement product briefs: muscle preservation during use, satiety support after discontinuation, GI comfort during titration, and metabolic maintenance during the off-ramp. Every major supplement retailer has carved out shelf space for "GLP-1 companion" SKUs, but the early entries have been protein powders with GLP-1 marketing rather than purpose-built formulas. Founders entering now have a 12–18 month window before category leaders emerge.

  • NielsenIQ: Weight management category report 2024: Identifies GLP-1 companion as the highest-growth subcategory in supplements, with $400M+ in projected 2025 revenue.
  • Examine.com: Berberine: Strong evidence base for glycemic and lipid effects. The most-studied of the GLP-1 stack metabolic actives.

References are provided for educational purposes. Citations do not constitute medical claims or guarantee outcomes. Structure-function claim language must be reviewed for your specific product and market.

Related Services

Custom formulation and R&D

Our formulators build your product from scratch. Most custom formulas take 8–12 weeks to develop, and you own 100% of the IP when it's done.

NPN application and Health Canada licensing

We prepare and file your Natural Product Number application. 100% first-time approval on every Class I and Class II NPN we've filed. Most consultants won't share their number.

Related Ingredients

Creatine Monohydrate

Creatine monohydrate is the most researched and most affordable form of creatine, with more than a thousand peer-reviewed studies behind it. It's expanding fast out of sports nutrition and into women's health, healthy aging, and cognitive formulas.

NMN (Nicotinamide Mononucleotide)

NMN is the most-discussed NAD+ precursor in longevity wellness, with real founder and consumer interest on both sides of the border. Before anyone ships an NMN product, the regulatory status in the US and Canada needs a current review. The rules here have changed recently and are still in motion.

Ready to build with GLP-1 Support Blend?

Tell us about your product concept and we'll put together a formulation, sourcing, and manufacturing plan tailored to your brand, format, and market.

Get a Free QuoteView All Ingredients